Tenet Healthcare (THC) Tops Q2 EPS by 114c; offers guidance
Tweet
Share
E-mail
Get Alerts THC Hot Sheet
Price: $264.56 -1.25%
Financial Fact:
Income (loss) from discontinued operations, net of tax: 1M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income (loss) from discontinued operations, net of tax: 1M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Tenet Healthcare (NYSE: THC) reported Q2 EPS of $4.02, $1.14 better than the analyst estimate of $2.88. Revenue for the quarter came in at $5.27 billion versus the consensus estimate of $5.16 billion.
GUIDANCE:
Tenet Healthcare sees FY2025 EPS of $15.55-$16.21, versus the consensus of $12.83. Tenet Healthcare sees FY2025 revenue of $20.95-21.25 million, versus the consensus of $20.92 million.
For earnings history and earnings-related data on Tenet Healthcare (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Golden Spike Resources plans name change, share consolidation and C$500K raise
- Kaiser Aluminum names Fred Stephan as CEO, effective November 2026
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
